@gustaaf
I would certainly think that management should decline to exercise their previously stated performance based options.
This would also reinforce imho to the market that the management team are here for the company and all its investors and not for themselves.
Quite frankly I can certainly understand why they have performance based options but was the target levels justified by the way the company recognised details in their 4Cs. If management have full faith in where this company is headed they would not have a problem in purchasing on market when the suspension is lifted.
Will have to wait and see what management do regarding these options.
- Forums
- ASX - By Stock
- BIG
- Ann: Company appointment of new Chairman
Ann: Company appointment of new Chairman, page-54
-
- There are more pages in this discussion • 235 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online